Stanford scientists have developed a trivalent CAR T cell that targets three proteins that are essential for self-renewal and differentiation of leukemic stem cells.
Stanford researchers in the WE3 and S3 Labs developed software for biogas modeling suitable for real-time, co-digestion forecasting control for waste streams with widely varying biodegradability rates.
Stanford researchers have identified a new therapeutic application for metformin in preventing corticosteroid-associated bone death, or osteonecrosis (ON).
Stanford researchers in Dr. Taia Wang's lab have developed a technology that utilizes swainsonine to enhance the cytotoxic potency of monoclonal antibodies, thereby improving their efficacy in cancer and autoimmune disease treatments.
Stanford researchers have developed a novel method to process raw genomic sequencing data into deep learning models directly, eliminating the dependency on genome assemblies with applications in drug discovery and diagnostics.
Stanford scientists have developed an advanced optical technology that can separate and recombine thousands of extremely close light frequencies with unprecedented precision.
Stanford researchers have patented a real-time auralization-reverberation system (CAVIAR - Chamber for Augmented Virtual and Interactive Audio Realities) for providing immersive and interactive audio environments.
Stanford researchers have developed a networked audio system that enhances the experience of teleconferencing, and online performances, gaming, and gatherings.
Stanford scientists have developed waterproofed six-axis robotic Stewart platforms that accurately replicate papillary muscle motion in ex vivo heart simulators.
Urethral catheterization is commonly performed during elective procedures, inpatient hospitalizations and long-term patient management, with more than 30 million indwelling catheters used annually in US.
Stanford scientists have developed a novel Nerve Decompression Brace capable of decompressing mild nerve compressions, which relieves forearm pain, numbness, and tingling symptoms associated with repetitive strain injuries.
Stanford scientists have developed a novel cardiac Ex-vivo Preservation System (EVPS) capable of maintaining hearts of any size warm and beating upon transport, expanding heart transplant options for pediatric populations.
Stanford scientists have developed DragonRNA, a novel method to produce DNA-capped RNA molecule by RNA polymerases, designed for enhanced stability and utility in RNA-based therapeutic and biotechnological applications.